Implementing a closed cell therapy manufacturing process through strategic collaboration
Øystein Åmellem, Xavier de Mollerat du Jeu, Brian Shy
13 April 2023
Innovator Insight
Regulatory requirements and product attributes for cGMP viral vector production
Scott Cross, Shikha Mishra
Regulatory requirements and product attributes for cGMP viral vector production
Scott Cross, Shikha Mishra
Scaling non-viral cell therapy approaches for solid tumor treatments
Evan Zynda, PhD, Nektaria Andronikou
The digital revolution: technological innovations to enable automation in cell therapy manufacturing
Bruce Greenwald, Sean Chang, Krish Roy
Scaling non-viral cell therapy approaches for solid tumor treatments
Evan Zynda, Nektaria Andronikou, Kyle Jacoby
23 May 2022
Innovator Insight
Strategic partnering to enable cell therapy commercialization
Jenessa Smith, Xavier de Mollerat du Jeu
The digital revolution: technological innovations to enable automation in cell therapy manufacturing
Sean Chang, Bruce Greenwald, Krishnendu Roy
12 April 2022
Innovator Insight
Scaling non-viral cell therapy approaches for solid tumor treatments
N Andronikou, E Zynda PhD, K Jacoby PhD
The digital revolution: Technological innovations to enable automation in cell therapy manufacturing
S Chang, B Greenwald, K Roy
Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing
Y Ji PhD, S Ensari PhD, N Moore PhD
Exploring the capabilities of a versatile, novel, automated closed system for cell and gene therapy manufacturing
Sarah Daoudi, Premkumar Jayaraman
25 March 2021
Innovator Insight
Exploring the capabilities of a versatile, novel, automated closed system for cell and gene therapy manufacturing
Premkumar Jayaraman PhD, Sarah Daoudi